For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
Medical device manufacturers and technology companies face a rapidly evolving regulatory and business environment, underscored by new mergers and partnerships between medical device and medical technology companies, increased regulatory scrutiny, rapid technological advancement, and growing cybersecurity threats.
Antitrust
As with any growing industry, we expect the medical device and technology fields to experience a surge in competition-related claims and antitrust concerns. NERA has provided assistance to clients involved in antitrust claims for half a century. Our experts combine institutional knowledge of the medical device market and a rigorous economic approach with a deep understanding of antitrust and competition law. The following are select examples of NERA services provided to our medical device clients:
Intellectual Property
NERA’s intellectual property economists apply thorough analysis in IP disputes to determine damages in connection with infringement and breach-of-contract claims involving patents and trade secrets for clients in the medical device industry. We also work with clients to address such issues as irreparable harm and the impact of alleged false or misleading advertising. Beyond this, our consultants work with medical device clients to value IP in connection with selling or licensing negotiations, preparing required transfer pricing documentation, obtaining advanced approval from a tax authority for the price of a particular trade flow or resolving a tax controversy. We help our clients identify portions of their IP portfolios that have value, develop strategies to manage risk, and use their IP for strategic advantage in the marketplace. The following are recent examples of our work:
Product Liability and Mass Torts
NERA economists work with medical device companies on projects related to product recalls, damages claims, insurance disputes, mergers and acquisitions and consumer class actions. Examples of recent matters include:
Securities
NERA’s securities and finance economists work with clients in the medical device and medical equipment industries to address allegations of product liability and securities fraud, to assist in resolving commercial disputes, and to manage financial, legal, and securities risks. Examples of recent matters include:
Transfer Pricing
Based throughout Europe and the US, NERA’s transfer pricing economists provide clients in the medical device and medical technology industries with expert analysis, valuation support, and advice on domestic and cross-border tax and valuation matters, and serve as expert witnesses in tax litigation and arbitration matters. Examples of recent work include:
Name | Title | Location | Phone | |
---|---|---|---|---|
Dr. Lawrence Wu | President | San Francisco | +1 415 291 1007 | lawrence.wu@nera.com |
Sarah Butler | Senior Managing Director | San Francisco | +1 415 291 1022 | sarah.butler@nera.com |
Dr. Yves Hervé | Senior Managing Director | Frankfurt | +49 69 710 447 508 | yves.herve@nera.com |
Bradley A. Heys | Senior Managing Director |
Toronto
New York City |
+1 416 868 7312
+1 212 345 3000 |
brad.heys@nera.com |
Dr. Vinita Juneja |
Senior Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice |
New York City
London Toronto |
+1 212 345 3148
+44 20 7659 8618 +1 416 868 7314 |
vinita.juneja@nera.com |
Dr. Christine Siegwarth Meyer |
Senior Managing Director
Chair of NERA's Intellectual Property Practice |
White Plains, NY | +1 914 448 4119 | christine.meyer@nera.com |
Dr. Lauren Stiroh | Senior Managing Director | White Plains, NY | +1 914 448 4143 | lauren.stiroh@nera.com |
Dr. David Blackburn | Managing Director | Washington, DC | +1 202 466 9264 | david.blackburn@nera.com |
Kristopher Boushie | Managing Director | Washington, DC | +1 202 466 9228 | kristopher.boushie@nera.com |
Mary Elizabeth C. Stern | Managing Director | White Plains, NY | +1 914 448 4054 | mary.elizabeth.stern@nera.com |
Dr. Chris Stomberg | Managing Director | Washington, DC | +1 202 466 9219 | chris.stomberg@nera.com |
Dr. Paul Wong | Managing Director | San Francisco | +1 415 291 1030 | paul.wong@nera.com |
Dr. Alan Cox | Affiliated Consultant | San Francisco | +1 415 291 1000 | alan.cox.affiliate@nera.com |
Dr. Thomas McCarthy | Affiliated Consultant | Los Angeles | +1 213 346 3000 | thomas.mccarthy.affiliate@nera.com |
Title | Date | |||
---|---|---|---|---|
GCR Live: Antitrust in Pharmaceuticals | 01 December 2022 | |||
Pharmaceutical Antitrust Updates: Latest Court Decisions, Congressional Bills, and Pr... | 17 February 2022 | |||
Developments in Pharma Antitrust: Evolution or Revolution? | 24 January 2022 | |||
16th Annual Paragraph IV Disputes Conference | 09 November 2021 | |||
NERA Insights Webinar | Pay What? Arbitrating Disputes in Pharmaceutical Contracts | 27 July 2021 | |||
Generics: Pay-For-Delay, Patent Settlements, Reverse Payment, Price-Fixing & Market A... | 24 June 2021 | |||
GCR Interactive: Pharmaceuticals | 11 March 2021 | |||
NERA Insights Webinar Series: Intellectual Property | 19 November 2020 | |||
Women Leaders in Life Sciences Law | 18 November 2020 | |||
Economic Trends in Pharma | 30 October 2020 | |||
Title | Date | Type | ||
---|---|---|---|---|
NERA Economic Consulting Announces Senior-Level Promotions | 28 July 2022 | Press Release | ||
NERA Economic Consulting Announces Senior-Level Promotions | 23 February 2021 | Press Release | ||
NERA Economic Consulting Announces Senior-Level Promotions | 19 March 2019 | Press Release | ||
|